Pay in 4 interest-free payments of $7.12 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Quick comparison: MEDVi is roughly $1,500 to $2,300 cheaper per year for cash-pay patients
Targeted, effective, and refreshingly simple
The research on semaglutide is compelling and continuing to grow
Repatha is a PCSK9 inhibitor, a class of medications designed to help lower LDL (bad) cholesterol levels by preventing the breakdown of LDL receptors in the liver
US$ 29.26
US$ 27.35
US$ 25.94
US$ 23.83
